Asper Biotech Overview

  • Founded
  • 1999
  • Status
  • Acquired/​Merged
  • Employees
  • 25
  • Latest Deal Type
  • M&A

Asper Biotech General Information


Provider of genetic testing services focusing on diagnostics for rare and common hereditary diseases. The company's testing portfolio's include research on ophthalmics, reprogenetics, oncogenetics, cardiogenetics, neurogenetics, otogenetics, hematology, and dysmorphology, enabling university hospitals, private clinics, commercial laboratories and research organizations access to genetic testing and research.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Drug Discovery
Asper Biogen
Primary Office
  • Oru 3
  • Tartu
  • Estonia
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Asper Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 01-Jul-2017 000 Completed Generating Revenue
1. Early Stage VC 000 000 Completed Generating Revenue
To view Asper Biotech’s complete valuation and funding history, request access »

Asper Biotech Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Asper Biotech Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Estonian Biocentre Corporation Majority 000 0000 000000 0
To view Asper Biotech’s complete investors history, request access »